Ronan O'Brien

Ronan O'Brien has a strong background in legal and compliance roles. Ronan currently serves as the Chief Legal Officer at Lyra Therapeutics since October 2023. Prior to that, they worked at Pear Therapeutics, where they held various positions such as General Counsel, Chief Compliance Officer & Secretary from January 2022 to April 2023, General Counsel & Secretary from January 2020 to January 2022, and Vice President, General Counsel & Secretary from March 2018 to January 2020. Before joining Pear Therapeutics, they worked at Selecta Biosciences as the Vice President & AGC from January 2018 to February 2018 and as an Associate General Counsel from September 2016 to January 2018. O'Brien also held roles at Cerulean Pharma Inc., where they served as the Executive Director & Associate General Counsel from January 2016 to September 2016, as an Associate General Counsel from September 2014 to January 2016, and as the General Counsel ad interim from June 2014 to September 2014. Earlier in their career, they worked as a Shareholder at Greenberg Traurig, LLP from May 2012 to June 2014, and as a Corporate Partner at Seyfarth Shaw LLP from 2006 to May 2012. O'Brien began their legal career as a Senior Associate in the Corporate Group at K&L Gates from 2001 to 2006.

Ronan O'Brien has a BA in English & French from Boston University. Ronan also attended Boston College High School and received a JD from Boston University School of Law. Additionally, Ronan studied French Language and Literature at Université Grenoble Alpes. However, no specific start or end years are provided for these educational experiences.